Therapy with radiolabeled somatostatin peptide analogs for metastatic neuroendocrine tumors.

作者信息

Bushnell David

机构信息

Diagnostic Imaging Service, Iowa City VAMC, and Radiology Department, University of Iowa Hospital and Clinics, 200 Hawkins Drive, 3856 JPP, Iowa City, IA 52242, USA.

出版信息

J Gastrointest Surg. 2006 Mar;10(3):335-6. doi: 10.1016/j.gassur.2005.08.025.

DOI:10.1016/j.gassur.2005.08.025

PMID:16622984

Abstract

摘要

相似文献

Therapy with radiolabeled somatostatin peptide analogs for metastatic neuroendocrine tumors.

J Gastrointest Surg. 2006 Mar;10(3):335-6. doi: 10.1016/j.gassur.2005.08.025.

Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors.生长抑素受体靶向放射性核素治疗胃肠胰神经内分泌肿瘤。

Endocrinol Metab Clin North Am. 2011 Mar;40(1):173-85, ix. doi: 10.1016/j.ecl.2010.12.003.

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.基于生长抑素受体的胃肠胰神经内分泌肿瘤的影像学诊断与治疗。

Endocr Relat Cancer. 2010 Jan 29;17(1):R53-73. doi: 10.1677/ERC-09-0078. Print 2010 Mar.

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.肿瘤的生长抑素受体靶向放射性核素治疗：临床前及临床研究结果

Semin Nucl Med. 2002 Apr;32(2):133-40. doi: 10.1053/snuc.2002.31027.

Targeted radiotherapy with radiolabeled somatostatin analogs.放射性标记生长抑素类似物的靶向放射治疗。

Endocrinol Metab Clin North Am. 2011 Mar;40(1):187-204, ix-x. doi: 10.1016/j.ecl.2010.12.006.

Tumor imaging and therapy using radiolabeled somatostatin analogues.使用放射性标记的生长抑素类似物进行肿瘤成像和治疗。

Acc Chem Res. 2009 Jul 21;42(7):873-80. doi: 10.1021/ar800188e.

[Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].[生长抑素受体闪烁扫描术在消化道和胰腺神经内分泌肿瘤诊断及分期中的应用]

Rev Esp Med Nucl. 2000 Jun;19(3):225-41.

Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives.生长抑素受体介导的成像与治疗：基础科学、当前认知、局限性及未来展望

Eur J Nucl Med. 2001 Sep;28(9):1421-9. doi: 10.1007/s002590100502.

Experience with indium-111 and yttrium-90-labeled somatostatin analogs.铟 - 111和钇 - 90标记的生长抑素类似物的经验。

Curr Pharm Des. 2002;8(20):1781-807. doi: 10.2174/1381612023393756.

Ten-Year Survival After Peptide Receptor Radionuclide Therapy of a Metastatic Well-differentiated G3 Pancreatic Neuroendocrine Neoplasm.一种转移性高分化 G3 胰腺神经内分泌肿瘤经肽受体放射性核素治疗后的 10 年生存。

Clin Nucl Med. 2018 Sep;43(9):676-678. doi: 10.1097/RLU.0000000000002186.

本文引用的文献

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.利用（90）Y-DOTATOC预测肾毒性时的个体剂量测定：肾脏体积和剂量率在确定剂量-效应关系中的相关性。

J Nucl Med. 2005 Jan;46 Suppl 1:99S-106S.

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.使用（90）Y-DOTA（0），Tyr（3）-奥曲肽和（177）Lu-DOTA（0），Tyr（3）-奥曲肽进行肽受体放射治疗后肾功能的长期随访

J Nucl Med. 2005 Jan;46 Suppl 1:83S-91S.

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.使用3种放射性标记生长抑素类似物进行肽受体放射性核素治疗的结果概述。

J Nucl Med. 2005 Jan;46 Suppl 1:62S-6S.

Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.使用¹⁷⁷镥和⁹⁰钇标记的生长抑素类似物的联合放射性核素治疗。

J Nucl Med. 2005 Jan;46 Suppl 1:13S-7S.

Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3]octreotate.接受[177Lu-DOTA0,Tyr3]奥曲肽治疗的胃肠胰腺肿瘤患者的生活质量

J Clin Oncol. 2004 Jul 1;22(13):2724-9. doi: 10.1200/JCO.2004.10.016.

Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment.静脉输注氨基酸联合Y-90 DOTA-苯丙氨酸1-酪氨酸3-奥曲肽（SMT487[奥曲肽疗法]）治疗的效果。

Cancer Biother Radiopharm. 2004 Feb;19(1):35-41. doi: 10.1089/108497804773391658.

Evaluating the clinical effectiveness of 90Y-SMT 487 in patients with neuroendocrine tumors.评估90Y-SMT 487对神经内分泌肿瘤患者的临床疗效。

J Nucl Med. 2003 Oct;44(10):1556-60.

86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion.86Y-二氧杂环辛烷（0）-D-苯丙氨酸1-酪氨酸3-奥曲肽（SMT487）——一项1期临床研究：不同氨基酸共输注方案的药代动力学、生物分布及肾脏保护作用

Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):510-8. doi: 10.1007/s00259-003-1117-1. Epub 2003 Feb 12.

Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.用于肿瘤治疗的放射性标记肽：现状与未来方向。在2002年欧洲核医学协会上的全会演讲。

Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):463-9. doi: 10.1007/s00259-002-1107-8. Epub 2003 Feb 5.

Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine.赖氨酸和精氨酸联合使用对放射性标记奥曲肽肾摄取的安全有效抑制作用。

Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):9-15. doi: 10.1007/s00259-002-0982-3. Epub 2002 Oct 29.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验